Aladdin-M by Topcon Launches in the US

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

August 28, 2020: Aladdin-M by Topcon, has been officially launched in the US. The news was announced today.

Aladdin-M combines corneal topography, pupillometry, and optical biometry to enable objective measurement of corneal curvature, pupil dynamics, and axial length metrics.

Topcon notes the versatile, all-in-one Aladdin-M provides the critical tools needed to support myopia management while also incorporating features for keratoconus screening and contact lens fitting. Aladdin-M’s exclusive software enables documentation of axial length measurements to identify risk factors and track changes in Rx and axial length measurements over time to show progression and response to treatment. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.

It is estimated that 50% of the world’s population may be myopic by 20501. With the launch of Aladdin-M, Topcon achieves a milestone in supporting the battle against this global myopia epidemic.

“Aladdin-M is ideally suited to help eye care professionals combat the growing crisis of myopia. Its versatility and ease of use allow eye care professionals to easily build a myopia service within their practice, educate patients on the implications of myopia, manage their patients’ conditions, and grow their service offerings,” stated John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare.

Topcon will debut the Aladdin-M device at the Vision Source Exchange On-Demand meeting, August 27th – 29th.


Reference

Holden, BA, Fricke,TR, Wilson, DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036–42. Available from: doi: DOI: 10.1016/j.ophtha.2016.01.006

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles